Kerri-Ann Millar
2022
In 2022, Kerri-Ann Millar earned a total compensation of $1.1M as Chief Financial Officer at Cue Biopharma.
Compensation breakdown
| Bonus | $137,000 |
|---|---|
| Option Awards | $497,890 |
| Salary | $418,459 |
| Other | $3,576 |
| Total | $1,056,925 |
Millar received $497.9K in option awards, accounting for 47% of the total pay in 2022.
Millar also received $137K in bonus, $418.5K in salary and $3.6K in other compensation.
Rankings
In 2022, Kerri-Ann Millar's compensation ranked 2,914th out of 5,760 executives tracked by ExecPay. In other words, Millar earned more than 49.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,914 out of 5,760 | 49th |
Division Manufacturing | 1,632 out of 3,136 | 48th |
Major group Chemicals And Allied Products | 763 out of 1,422 | 46th |
Industry group Drugs | 712 out of 1,323 | 46th |
Industry Pharmaceutical Preparations | 516 out of 969 | 47th |
Source: SEC filing on April 26, 2024.
Millar's colleagues
We found two more compensation records of executives who worked with Kerri-Ann Millar at Cue Biopharma in 2022.